Compare WLK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLK | PEN |
|---|---|---|
| Founded | 1986 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 10.9B |
| IPO Year | 2004 | 2015 |
| Metric | WLK | PEN |
|---|---|---|
| Price | $67.75 | $299.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | $88.00 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 1.6M | 479.9K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | N/A | ★ 4.14 |
| Revenue | ★ $11,480,000,000.00 | $1,333,798,000.00 |
| Revenue This Year | N/A | $16.77 |
| Revenue Next Year | $3.18 | $14.12 |
| P/E Ratio | ★ N/A | $72.65 |
| Revenue Growth | N/A | ★ 14.61 |
| 52 Week Low | $56.33 | $221.26 |
| 52 Week High | $128.85 | $310.00 |
| Indicator | WLK | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 67.77 |
| Support Level | $56.33 | $284.95 |
| Resistance Level | $70.31 | $298.69 |
| Average True Range (ATR) | 2.88 | 8.02 |
| MACD | 1.42 | 0.11 |
| Stochastic Oscillator | 83.23 | 91.50 |
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.